However, serious arrhythmias that are prolonged and significantly disrupt heart function are very dangerous
On the kidneys, a pooled analysis of Phase 2 obesity and type 2 diabetes data showed reductions in the standard kidney-injury marker (the urine albumin-to-creatinine ratio, or UACR) of approximately 37% in adults with type 2 diabetes and 31.5% in adults with obesity but no type 2 diabetes, both on the 12 mg dose [12]
The drug is designed to activate the glucagon receptor as part of a combined metabolic effect
Its unlicensed peptide stock, counterfeit pens, or both
Builes-Montao has received consulting or speaker fees from Sanofi, Novo Nordisk, Novartis, and Boehringer Ingelheim
Always consult with a qualified healthcare provider before starting any peptide therapy